Pipeline in a Molecule:
A new paradigm in oncology to effectively and safely treat, perhaps cure, patients with most lethal primary solid tumors. Clinical evidence for GBM/HGG and precloinical fopr other solid tuimors. Proprietary formulated drug, with great promise for GBM ready for regulatory process, excellent clinical evidence. Exceptional promise for PDAC and other solid tumors.
Partners, companies, drug developers are welcome to take this to the clinic and save countless lives of people suffering from these deadly solid tumors or brain and pancreas.
VCs interested in company formation are welcome. Open to licensing or let them drive the path forward.
Largely clinically de-risked with excellent safety and efficacy evidence.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Boston, Us
- Industry
- Biotechnology
- Keywords
- Philadelphia.
- HQ
- Boston
Sefacor Inc. Questions
Sefacor Inc.'s LinkedIn profile is https://www.linkedin.com/company/sefacor-inc-
Sefacor Inc. has
5 employees.
View email and phone details for 5
employees at Sefacor Inc..
Sefacor Inc.'s industry is
Biotechnology
Sefacor Inc.'s top competitors are
Breton Technology,
Erasavir,
Obio Tech,
Saptalis Pharmaceuticals, Llc,
Strassenburg Pharmaceuticals,
Neopharm Boston,
Bpgbio, Inc.,
Big Tree Memorial Fund,
Bruker Spatial Genomics, Inc.,
Endevica Bio.
Sefacor Inc.'s categories are Biotechnology
Sefacor Inc.'s founding year is 2013
